Sectors
AQST
Aquestive Therapeutics, Inc.
5.11
2 x 2.67
2 x 4.78
bid
ask
+
0.09
1.79%
2 @ 04:00 PM
5.15 +0.04 (0.69%)
| Ytd | -20.90% | |
| 1y | 35.54% |
4.91
day range
5.13
2.93
52 week range
7.55
| Open | 4.97 | Prev Close | 5.02 | Low | 4.91 | High | 5.13 | Mkt Cap | 641.36M |
| Vol | 1.91M | Avg Vol | 2.64M | EPS | -0.66 | P/E | N/A | Forward P/E | -5.87 |
| Beta | 2.82 | Short Ratio | 6.37 | Inst. Own | 55.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 4.25 | 200-d Avg | 4.47 | 1yr Est | 10.83 |
| Income Statement | |||
| Total Revenue | 13.82M | ||
| Revenues (USD) | 13.82M | ||
| Cost of Revenue | 4.02M | ||
| Gross Profit | 9.80M | ||
| Operating Expenses | 18.02M | ||
| Research and Development Expense | 3.96M | ||
| Selling, General and Administrative Expense | 14.06M | ||
| Operating Income | -8.22M | ||
| Interest Expense | 3.84M | ||
| Net Income | -22.86M | ||
| Net Income Common Stock | -22.86M | ||
| Net Income Common Stock (USD) | -22.86M | ||
| Consolidated Income | -22.86M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -19.02M | ||
| Earning Before Interest & Taxes (USD) | -19.02M | ||
| Weighted Average Shares | 124.99M | ||
| Weighted Average Shares Diluted | 124.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 98.49M | ||
| Cash and Equivalents (USD) | 98.49M | ||
| Trade and Non-Trade Receivables | 9.33M | ||
| Current Assets | 118.49M | ||
| Property, Plant & Equipment Net | 11.91M | ||
| Total Assets | 132.10M | ||
| Debt Current | 1.85M | ||
| Total Debt | 149.03M | ||
| Current Liabilities | 16.48M | ||
| Debt Non-Current | 147.18M | ||
| Total Liabilities | 188.69M | ||
| Accumulated Retained Earnings (Deficit) | -477.92M | ||
| Shareholders Equity | -56.59M | ||
| Shareholders Equity (USD) | -56.59M | ||
| Assets Non-Current | 13.61M | ||
| Total Debt (USD) | 149.03M | ||
| Deferred Revenue | 19.94M | ||
| Inventory | 7.37M | ||
| Liabilities Non-Current | 172.21M | ||
| Trade and Non-Trade Payables | 8.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 136.00K | ||
| Net Cash Flow from Financing | -2.59M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.24M | ||
| Capital Expenditure | -212.00K | ||
| Issuance (Purchase) of Equity Shares | 17.00K | ||
| Issuance (Repayment) of Debt Securities | -30.00K | ||
| Net Cash Flow from Investing | -212.00K | ||
| Net Cash Flow from Operations | -9.44M | ||
| Share Based Compensation | 2.90M | ||